Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 2,018 shares of the stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $111.97, for a total value of $225,955.46. Following the completion of the transaction, the executive vice president now directly owns 27,749 shares in the company, valued at $3,107,055.53. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Varian Medical Systems, Inc. (NYSE VAR) traded up $2.10 during trading hours on Friday, reaching $111.87. The company’s stock had a trading volume of 883,273 shares, compared to its average volume of 645,538. Varian Medical Systems, Inc. has a one year low of $76.94 and a one year high of $114.09. The stock has a market capitalization of $10,056.79, a price-to-earnings ratio of 29.12, a PEG ratio of 3.23 and a beta of 0.67.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings data on Wednesday, October 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.10). Varian Medical Systems had a net margin of 8.85% and a return on equity of 23.68%. The company had revenue of $739.00 million during the quarter, compared to analysts’ expectations of $741.69 million. During the same period last year, the business earned $1.03 earnings per share. The company’s revenue for the quarter was down 1.1% compared to the same quarter last year. equities research analysts expect that Varian Medical Systems, Inc. will post 4.25 EPS for the current fiscal year.

Several brokerages recently weighed in on VAR. Royal Bank of Canada set a $105.00 target price on Varian Medical Systems and gave the stock a “hold” rating in a research report on Thursday, November 30th. BTIG Research reaffirmed a “hold” rating on shares of Varian Medical Systems in a research report on Sunday, October 29th. Citigroup increased their target price on Varian Medical Systems from $119.00 to $121.00 and gave the stock a “neutral” rating in a research report on Monday, October 30th. Zacks Investment Research lowered Varian Medical Systems from a “hold” rating to a “sell” rating in a research report on Friday, October 27th. Finally, Robert W. Baird reissued a “hold” rating and issued a $99.00 price objective on shares of Varian Medical Systems in a research report on Monday, August 28th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and one has issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $98.39.

A number of large investors have recently added to or reduced their stakes in VAR. Vanguard Group Inc. grew its stake in shares of Varian Medical Systems by 1.7% during the second quarter. Vanguard Group Inc. now owns 9,157,677 shares of the medical equipment provider’s stock valued at $944,980,000 after acquiring an additional 150,482 shares in the last quarter. BlackRock Inc. grew its stake in shares of Varian Medical Systems by 6.6% during the second quarter. BlackRock Inc. now owns 8,423,626 shares of the medical equipment provider’s stock valued at $869,233,000 after acquiring an additional 523,858 shares in the last quarter. First Eagle Investment Management LLC grew its stake in shares of Varian Medical Systems by 2.1% during the third quarter. First Eagle Investment Management LLC now owns 4,778,741 shares of the medical equipment provider’s stock valued at $478,161,000 after acquiring an additional 99,270 shares in the last quarter. Janus Henderson Group PLC grew its stake in shares of Varian Medical Systems by 1,545.7% during the second quarter. Janus Henderson Group PLC now owns 3,754,727 shares of the medical equipment provider’s stock valued at $387,450,000 after acquiring an additional 3,526,571 shares in the last quarter. Finally, Fiera Capital Corp grew its stake in shares of Varian Medical Systems by 12.0% during the second quarter. Fiera Capital Corp now owns 2,519,976 shares of the medical equipment provider’s stock valued at $260,037,000 after acquiring an additional 269,633 shares in the last quarter. 99.15% of the stock is currently owned by institutional investors.

WARNING: “Insider Selling: Varian Medical Systems, Inc. (VAR) EVP Sells $225,955.46 in Stock” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international copyright law. The legal version of this report can be viewed at https://www.watchlistnews.com/insider-selling-varian-medical-systems-inc-var-evp-sells-225955-46-in-stock/1767996.html.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with Analyst Ratings Network's FREE daily email newsletter.